Fonte: European Journal of Pharmaceutical Sciences. Unidade: ICB
Assuntos: MICROBIOLOGIA, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS CUTÂNEAS, ANTINEOPLÁSICOS, MELANOMA, ANIMAIS, CANDIDA ALBICANS, MICOSES, PELE, NANOTECNOLOGIA, ANTIFÚNGICOS
ABNT
MIGUEL, Rodrigo dos Anjos et al. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase. European Journal of Pharmaceutical Sciences, v. 192, p. 14 , 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2023.106635. Acesso em: 21 ago. 2024.APA
Miguel, R. dos A., Hirata, A. S., Salata, G. C., Apolinário, A. C., Barroso, V. de M., Clair, J. J. L., et al. (2023). Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase. European Journal of Pharmaceutical Sciences, 192, 14 . doi:10.1016/j.ejps.2023.106635NLM
Miguel R dos A, Hirata AS, Salata GC, Apolinário AC, Barroso V de M, Clair JJL, Fenical W, Martins TS, Costa-Lotufo LV, Ishida K, Lopes LB. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 192 14 .[citado 2024 ago. 21 ] Available from: https://doi.org/10.1016/j.ejps.2023.106635Vancouver
Miguel R dos A, Hirata AS, Salata GC, Apolinário AC, Barroso V de M, Clair JJL, Fenical W, Martins TS, Costa-Lotufo LV, Ishida K, Lopes LB. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 192 14 .[citado 2024 ago. 21 ] Available from: https://doi.org/10.1016/j.ejps.2023.106635